XERS - Xeris Pharmaceuticals, Inc

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

XERS is currently covered by 1 analysts with average potential upside of $4.9 (111.95%) backed by 1 price targets and 5 ratings. Documented since 17-Jul-2018. Analyst's average stock valuation to be materialised ratio is 50% with an average time for price targets to be met of 18.5 days.

Most recent stock forecast was given by OREN LIVNAT from HCWAINWRIGHT on 09-Mar-2023.

Highest price target for XERS is 3, Lowest price target is 1, average price target is 2.

Best performing analysts who are covering XERS - Xeris Pharmaceuticals, Inc:

Difei Yang Oren Livnat

Currently, out of the existing stock ratings of XERS - 2 which are a Buy (100%)

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score



$4.72 (368.75%)


18 days ago

0/3 (0%)

$3.08 (189.12%)



4 years 4 months 18 days ago

1/1 (100%)

$6.71 (34.78%)


Show more analysts

What is XERS(Xeris Pharmaceuticals, Inc) average time for price targets to be met?

On average it took 18.5 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on XERS(Xeris Pharmaceuticals, Inc) with a proven track record?